Northern Trust’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.13M Buy
643,919
+56,091
+10% +$186K ﹤0.01% 2942
2025
Q1
$1.7M Sell
587,828
-11,984
-2% -$34.8K ﹤0.01% 3002
2024
Q4
$2.14M Buy
599,812
+18,199
+3% +$64.8K ﹤0.01% 2990
2024
Q3
$2.9M Buy
581,613
+387,589
+200% +$1.93M ﹤0.01% 2772
2024
Q2
$504K Buy
194,024
+96,104
+98% +$250K ﹤0.01% 3507
2024
Q1
$417K Buy
97,920
+6,728
+7% +$28.7K ﹤0.01% 3622
2023
Q4
$184K Buy
91,192
+25,692
+39% +$51.9K ﹤0.01% 3927
2023
Q3
$100K Hold
65,500
﹤0.01% 4014
2023
Q2
$108K Buy
65,500
+5,672
+9% +$9.36K ﹤0.01% 4017
2023
Q1
$68.2K Sell
59,828
-2,262
-4% -$2.58K ﹤0.01% 4183
2022
Q4
$56K Hold
62,090
﹤0.01% 4258
2022
Q3
$73K Buy
62,090
+14,541
+31% +$17.1K ﹤0.01% 4213
2022
Q2
$30K Sell
47,549
-10
-0% -$6 ﹤0.01% 4553
2022
Q1
$124K Buy
47,559
+10
+0% +$26 ﹤0.01% 4284
2021
Q4
$185K Buy
47,549
+1,820
+4% +$7.08K ﹤0.01% 4221
2021
Q3
$199K Buy
45,729
+275
+0.6% +$1.2K ﹤0.01% 4181
2021
Q2
$181K Sell
45,454
-166,948
-79% -$665K ﹤0.01% 4195
2021
Q1
$1.1M Sell
212,402
-13,202
-6% -$68.6K ﹤0.01% 3547
2020
Q4
$1.21M Sell
225,604
-6,299
-3% -$33.7K ﹤0.01% 3440
2020
Q3
$1.13M Sell
231,903
-5,852
-2% -$28.4K ﹤0.01% 3347
2020
Q2
$1.16M Buy
237,755
+190,451
+403% +$926K ﹤0.01% 3305
2020
Q1
$104K Buy
47,304
+33,327
+238% +$73.3K ﹤0.01% 3807
2019
Q4
$81K Sell
13,977
-826
-6% -$4.79K ﹤0.01% 3969
2019
Q3
$47K Sell
14,803
-83,839
-85% -$266K ﹤0.01% 4056
2019
Q2
$414K Sell
98,642
-7,628
-7% -$32K ﹤0.01% 3607
2019
Q1
$734K Buy
106,270
+48,201
+83% +$333K ﹤0.01% 3446
2018
Q4
$366K Buy
58,069
+317
+0.5% +$2K ﹤0.01% 3625
2018
Q3
$1.01M Buy
+57,752
New +$1.01M ﹤0.01% 3465